These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 747905)

  • 1. cis-Platinum ototoxicity.
    Helson L; Okonkwo E; Anton L; Cvitkovic E
    Clin Toxicol; 1978; 13(4):469-78. PubMed ID: 747905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-platinum ototoxicity in children.
    Pasic TR; Dobie RA
    Laryngoscope; 1991 Sep; 101(9):985-91. PubMed ID: 1886448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-platinum ototoxicity in children.
    Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
    Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.
    Kopelman J; Budnick AS; Sessions RB; Kramer MB; Wong GY
    Laryngoscope; 1988 Aug; 98(8 Pt 1):858-64. PubMed ID: 3398663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
    Riedemann L; Lanvers C; Deuster D; Peters U; Boos J; Jürgens H; am Zehnhoff-Dinnesen A
    Pharmacogenomics J; 2008 Feb; 8(1):23-8. PubMed ID: 17457342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ototoxicity of cisplatin: a clinical study].
    Vantrappen G; Rector E; Debruyne F
    Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
    Miller MW; Riedel G; Hoistad D; Sutherland C; Juhn SK; Adams GL; Griffin R; Ondrey FG
    Am J Otolaryngol; 2009; 30(1):1-7. PubMed ID: 19027506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cisplatin treatment: hearing loss and plasma concentrations.
    Laurell G; Jungnelius U
    Laryngoscope; 1990 Jul; 100(7):724-34. PubMed ID: 2362532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of acoustic reflex thresholds and other conventional audiologic tests for monitoring cisplatin ototoxicity in the pediatric population.
    Park KR
    Ear Hear; 1996 Apr; 17(2):107-15. PubMed ID: 8698156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
    Knight KR; Kraemer DF; Neuwelt EA
    J Clin Oncol; 2005 Dec; 23(34):8588-96. PubMed ID: 16314621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
    Waters GS; Ahmad M; Katsarkas A; Stanimir G; McKay J
    Ear Hear; 1991 Apr; 12(2):91-102. PubMed ID: 2065844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ototoxicity of cis-diamminedichloroplatinum.
    Vodvárka P; Foukalová J; Mrázek J; Philippová J
    Neoplasma; 1985; 32(2):229-38. PubMed ID: 4039797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.